Articles tagged "Donors, marginal"

2020 American Transplant Congress
Utilization of Organs from Donors Exposed to Hepatitis C: ? Standard of Care
M. Marvin¹, S. Gaines², P. Mohan³, A. Kotru¹, C. Koo¹, B. Addissie⁴, A. Unzueta⁴, S. Khurana⁴
¹Transplantation and Liver Surgery, Geisinger, Danville, PA, ²Pharmacy, Geisinger, Danville, PA, ³Nephrology, Geisinger, Danville, PA, ⁴Hepatology, Geisinger, Danville, PA
*Purpose: To report the results of a clinical program to utilize livers and kidneys from donors exposed to Hepatitis C.*Methods: We initially started to explore…
2020 American Transplant Congress
The Impact of Preoperative Glucose Intolerance and Hypertension on the Living Kidney Donors
T. Hiramitsu¹, T. Tomosugi¹, K. Futamura¹, M. Okada¹, N. Goto¹, S. Narumi¹, K. Uchida², Y. Watarai¹
¹Department of Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya Aichi, Japan, ²Department of Transplant Surgery, Masuko Memorial Hospital, Nagoya Aichi, Japan
*Purpose: Recently the mortality of living kidney donors was demonstrated to be significantly worse than that of healthy general population. However, the impact of preoperative…
2020 American Transplant Congress
Utilization of High Terminal Creatinine Kidney Donors for Simultaneous Kidney and Pancreas Transplantation
A. Montal, J. Torabi, N. Muhdi, J. Melvin, Y. Miura, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, E. Akalin, S. Greenstein, J. P. Rocca, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: The use of kidneys with high terminal creatinine has been demonstrated in renal transplantation with excellent outcomes. Here we explore the use of high…
2020 American Transplant Congress
Selectively Transplanting Moderately to Severely Macrosteatotic Grafts: Does Recipient Metabolic Environment Affect Outcomes?
P. J. Altshuler, A. Rios Diaz, O. Shaheen, A. P. Shah, W. R. Maley, A. Frank, C. Ramirez, J. Glorioso, H. Dang, A. S. Bodzin
Department of Surgery, Thomas Jefferson University, Philadelphia, PA
*Purpose: As incidence of Non-Alcoholic Steatohepatitis (NASH) cirrhosis rises, organ utilization remains stagnant. Recently, it has been shown that selective utilization of >30% macrosteatotic grafts…
2020 American Transplant Congress
Beyond the Margin: Using Kidneys from Donors on Dialysis
P. S. Patel¹, S. Karir², V. R. Peddi¹, H. Mahanty¹, S. Katznelson¹, J. Bellingham¹, N. Neidlinger¹, A. Hassoun¹, A. Sandhu¹, N. Garg¹, L. Mayen³, W. Bry¹
¹CPMC Dept of Transplantation, San Francisco, CA, ²Lewis and Clark College, Portland, OR, ³Donor Network West, San Ramon, CA
*Purpose: Outcomes for transplantation from donors with acute kidney injury have been favorable. The definition and severity of AKI have been variable. Donors who are…
2020 American Transplant Congress
Liver Transplant Outcomes in Deceased Donors with Elevated Bilirubin: A Large Database Analysis
P. J. Altshuler, A. Rios Diaz, O. Shaheen, A. P. Shah, W. R. Maley, A. Frank, J. Glorioso, C. Ramirez, H. Dang, A. S. Bodzin
Department of Surgery, Thomas Jefferson University, Philadelphia, PA
*Purpose: Significant hepatic injury and impairments in biliary excretion manifest serologically in elevated bilirubin levels. Despite a direct linkage between hyperbilirubinemia and hepatobiliary dysfunction, significance…
2020 American Transplant Congress
Outcomes after Declining Offers from Older Donor Kidneys for Kidney Transplant Candidates
J. D. Motter, L. Liyanage, K. R. Jackson, M. G. Bowring, T. Ishaque, Y. Yu, S. Yu, J. M. Garonzik-Wang, A. B. Massie, D. L. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: Older donor kidneys (ODKs) are often declined as they are associated with higher post-transplant mortality and graft loss, yet those who decline may wait…
2020 American Transplant Congress
Viral Kinetics of De Novo HCV Infection and Response to Antiviral Therapy in Liver and Kidney Transplant Recipients Receiving HCV-Viremic Donors
N. Terrault¹, J. Burton², E. Verna³, C. Mobley⁴, D. Victor⁴, J. Trotter⁵, C. Niemann⁶, R. Rubin⁷
¹University of Southern California, Los Angeles, CA, ²UC, Denver, CO, ³Columbia Universeity, New York, NY, ⁴Houston Methodist, Houston, TX, ⁵Baylor University, Dallas, TX, ⁶UCSF, San Francisco, CA, ⁷Piedmont Atlanta Hosptial, Atlanta, GA
*Purpose: There is general agreement that expanded use of organs from HCV-viremic donors is desirable, including in recipients without HCV infection. However, the optimal treatment…
2020 American Transplant Congress
The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is it Time to Split the Difference?
D. Yoeli¹, M. Adams¹, R. Choudhury¹, T. Nydam¹, J. Pomposelli¹, J. Goss², M. Wachs¹
¹Transplant Surgery, University of Colorado, Aurora, CO, ²Transplant Surgery, Baylor College of Medicine, Houston, TX
*Purpose: The opioid epidemic afflicting our nation has led to a surge in the number of adult deceased donors from drug overdose. We hypothesized that…
2020 American Transplant Congress
Should Steatotic Livers Be Transplanted Into Pediatric Recipients?
M. MacConmara, C. Feizpour, P. Vagefi, C. Ramirez, L. DeGregorio, C. S. Hwang
UT Southwestern, Dallas, TX
*Purpose: Although steatotic livers are frequently transplanted in the adult population, they are not commonly transplanted in pediatric recipients. We questioned if the outcomes of…